Paul Peloso
Plus aucun poste en cours
Fortune : 1 M $ au 31/03/2024
Profil
Paul M.
Peloso worked as the Group Medical Director-Clinical Development at AbbVie, Inc. from 2013 to 2018.
He then served as the Chief Medical Officer at ACELYRIN, Inc. from 2021 to 2023.
Mr. Peloso obtained his graduate degree from the University of Toronto, his undergraduate degree from McMaster University, and his doctorate from the University of Calgary.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ACELYRIN, INC.
0,17% | 04/10/2023 | 160 644 ( 0,17% ) | 1 M $ | 31/03/2024 |
Anciens postes connus de Paul Peloso
| Sociétés | Poste | Fin |
|---|---|---|
| ACELYRIN, INC. | Chief Tech/Sci/R&D Officer | 31/12/2023 |
| ABBVIE INC. | Chief Tech/Sci/R&D Officer | 01/05/2018 |
Formation de Paul Peloso
| University of Toronto | Graduate Degree |
| McMaster University | Undergraduate Degree |
| University of Calgary | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ABBVIE INC. | Health Technology |
| ACELYRIN, INC. | Health Technology |
